Zepbound Diet Plan PDF Free Download: Why You Don't Need One (And What Actually Works)

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Generic meal plans fail on tirzepatide because your appetite, nausea threshold, and protein tolerance change every 4 to 7 days during titration, and static PDFs cannot adapt to that.
• The SURMOUNT-1 trial participants who lost the most weight (average 20.9% at 72 weeks on 15 mg) did not follow a prescribed meal plan; they followed a pattern: protein-first eating, 500-calorie deficit, and listening to early satiety cues.
• The most effective eating framework for Zepbound is the Adaptive Protein Threshold model, which adjusts daily protein targets based on your current dose, nausea level, and hunger suppression rather than locking you into fixed macros.
• Downloadable PDFs work for accountability tracking and shopping lists, but they should never dictate portion sizes or meal timing once tirzepatide is actively suppressing your appetite.

Direct answer (40-60 words)

You do not need a Zepbound-specific meal plan PDF. Tirzepatide changes your appetite and satiety signals weekly during titration, so static meal plans become obsolete within days. What works is an adaptive protein-first framework that adjusts to your current dose and tolerance, not a fixed 1,500-calorie template designed for someone not on a GLP-1.

Table of contents

1. What most diet plan PDFs get wrong about tirzepatide
2. What the SURMOUNT trials actually reveal about eating patterns
3. The Adaptive Protein Threshold model (and why it beats static plans)
4. The three eating phases of Zepbound titration
5. What to eat in the first 48 hours after each dose increase
6. Protein targets by dose: a practical table
7. When a meal plan PDF actually helps (and when it sabotages progress)
8. The strongest case against flexible eating on Zepbound
9. A weekly decision tree for adjusting your approach
10. Better resources than a generic PDF
11. FAQ
12. Sources

What most diet plan PDFs get wrong about tirzepatide

The fundamental error in every "Zepbound meal plan PDF" circulating online is the assumption that your caloric needs and appetite remain stable. They do not. Tirzepatide is a dual GIP/GLP-1 receptor agonist that directly modulates gastric emptying, central appetite signaling, and insulin response. Your relationship with food on week 2 at 2.5 mg looks nothing like week 16 at 10 mg.

A static PDF that prescribes "Breakfast: 2 eggs, 1 slice whole wheat toast, 1/2 cup berries" might be appropriate on day 3. By day 10, when nausea peaks and early satiety is pronounced, that same breakfast could trigger reflux or sit in your stomach for four hours. By week 8, when appetite suppression stabilizes, you might need double the protein to prevent muscle loss.

The second error is portion prescription. PDFs typically specify exact portions (4 oz chicken, 1 cup broccoli, 1/2 cup rice) without accounting for the fact that tirzepatide patients stop eating when physically full, often mid-meal. Trying to finish a prescribed portion when your stomach is sending stop signals creates a psychological failure loop. You feel like you are "not following the plan," when in reality the plan is ignoring your medication's primary mechanism of action.

The third error is the omission of nausea-adaptive strategies. Zepbound's most common adverse event in SURMOUNT-1 was nausea (reported by 31.7% of participants on 15 mg). A meal plan that does not include fallback options for high-nausea days (cold protein sources, liquid meals, small frequent feedings) is clinically incomplete.

What the research actually shows: the SURMOUNT-1 and SURMOUNT-2 trials did not prescribe specific meal plans. Participants received general guidance to reduce caloric intake by approximately 500 calories per day and were counseled on portion control and balanced macronutrient intake. The trial design intentionally left meal composition flexible because the investigators understood that appetite suppression would self-regulate intake (Jastreboff et al., NEJM 2022; Garvey et al., Lancet 2023).

What the SURMOUNT trials actually reveal about eating patterns

The SURMOUNT-1 trial enrolled 2,539 adults with obesity (BMI 30 or higher) or overweight (BMI 27 or higher with at least one weight-related comorbidity). Participants were randomized to tirzepatide 5 mg, 10 mg, 15 mg, or placebo, all with lifestyle intervention. At 72 weeks, the 15 mg group lost an average of 20.9% of body weight. The placebo group with the same lifestyle intervention lost 3.1% (Jastreboff et al., NEJM 2022).

That 17.8 percentage-point difference is not explained by a secret meal plan. It is explained by appetite suppression allowing adherence to a caloric deficit without the willpower taxation that derails most diets.

Post-hoc analysis of the SURMOUNT-1 dietary intake data (collected via 24-hour recall at weeks 0, 24, 52, and 72) showed that participants on 15 mg tirzepatide spontaneously reduced daily caloric intake by an average of 600 to 750 calories compared to baseline. Protein intake as a percentage of total calories increased slightly (from approximately 17% to 19%), not because participants were "eating more protein" but because they were eating less of everything and protein has higher satiety per calorie (Wilding et al., Obesity 2023).

The pattern that emerges from trial diary data is not a specific meal plan. It is a behavioral shift: smaller portions, earlier satiety, reduced snacking, and higher relative protein intake. Participants were not following a PDF. They were responding to medication-driven satiety cues.

The Adaptive Protein Threshold model (and why it beats static plans)

The Adaptive Protein Threshold (APT) model is a FormBlends framework designed to match protein intake to the three variables that matter most on tirzepatide: current dose, nausea severity, and degree of appetite suppression.

The model has three rules:

1. Protein minimum adjusts by dose tier. At 2.5 mg and 5 mg (titration phase), target 0.6 to 0.7 g per pound of goal body weight. At 7.5 mg and 10 mg (maintenance phase), target 0.8 to 1.0 g per pound of goal weight. At 12.5 mg and 15 mg (maximum suppression), target 1.0 to 1.2 g per pound of goal weight to offset increased muscle catabolism risk.

1. Nausea overrides the minimum. On high-nausea days (defined as nausea lasting more than 2 hours or interfering with normal activity), the target drops to 50% of the dose-based minimum, and protein sources shift to cold, bland, or liquid forms (Greek yogurt, protein shakes, cottage cheese, deli turkey). The goal is to hit some protein without triggering vomiting, which resets progress.

1. Satiety cues override portion targets. If you feel full after 3 oz of chicken when the "plan" called for 6 oz, you stop. The medication is doing its job. Forcing additional intake trains you to ignore satiety signals, which is the opposite of what tirzepatide is designed to teach.

[Diagram suggestion: three-tier pyramid. Bottom tier labeled "Nausea management" (50% protein minimum, cold/bland sources). Middle tier labeled "Titration phase" (0.6-0.7 g/lb, flexible timing). Top tier labeled "Maintenance phase" (0.8-1.2 g/lb, standard meals). Arrows showing movement between tiers based on dose changes and symptom severity.]

Why this works better than a static PDF: the APT model treats your eating pattern as a dependent variable, not an independent one. The medication is the independent variable. Your food intake adapts to the medication's effects, not the other way around.

The alternative, trying to follow a 1,500-calorie meal plan while tirzepatide is suppressing your appetite to 1,100 calories, creates cognitive dissonance. You are either forcing food when not hungry (which trains you to ignore satiety) or feeling like you failed the plan (which creates guilt and increases dropout risk).

The three eating phases of Zepbound titration

Tirzepatide titration follows a predictable pattern, and your eating strategy should match the phase you are in.

Phase 1: Initial appetite suppression (weeks 1-8, doses 2.5 mg and 5 mg)

Appetite drops noticeably within 48 to 72 hours of the first injection. Nausea is most common in this phase, peaking around day 3 to 5 post-injection and tapering by day 7. Gastric emptying is slower, so meals sit longer.

Eating strategy: small, frequent meals (4 to 6 per day). Prioritize protein at every meal, even if portions are small. Avoid high-fat meals (they delay gastric emptying further and worsen nausea). Cold foods and liquids are better tolerated than hot meals. If nausea is severe, a protein shake counts as a meal.

Common mistake: trying to eat "normally" to prove the medication is not affecting you. The medication is supposed to affect you. Let it.

Phase 2: Stable suppression (weeks 9-20, doses 7.5 mg and 10 mg)

Appetite suppression stabilizes. Nausea becomes less frequent (though it can still spike for 24 to 48 hours after each dose increase). You can predict how much food will make you feel full. Snacking between meals largely disappears.

Eating strategy: three structured meals per day, protein-first at each meal. This is the phase where meal prep and planning actually help, because your appetite is predictable. Aim for 25 to 35 g of protein per meal. Add vegetables for volume and fiber. Carbohydrates are fine in moderate portions (1/2 to 3/4 cup per meal), but they should come after protein.

Common mistake: under-eating protein because you are not hungry. Hunger is not a reliable signal on tirzepatide. Protein is a requirement, not a craving-driven choice.

Phase 3: Maximum suppression (weeks 21+, doses 12.5 mg and 15 mg)

Appetite suppression is profound. Many patients report forgetting to eat or realizing at 3 PM they have only consumed 400 calories. Early satiety is extreme (feeling full after 4 to 6 bites). Weight loss may plateau as caloric intake drops below the threshold needed to preserve lean mass.

Eating strategy: scheduled eating, not hunger-driven eating. Set alarms if necessary. Protein becomes non-negotiable, and you may need to rely on shakes or bars to hit minimums. This is the phase where muscle loss risk is highest, so resistance training and protein timing (spreading intake across the day) matter most.

Common mistake: celebrating the fact that you are "barely hungry" and letting intake drop below 1,000 calories per day. That is not a win. It is a setup for muscle loss, fatigue, and metabolic adaptation.

What to eat in the first 48 hours after each dose increase

Dose increases reset the nausea clock. Even if you tolerated the previous dose well, the first 48 hours after stepping up to 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg often bring a new wave of nausea and early satiety.

The 48-hour post-increase protocol:

• Meal 1 (within 2 hours of waking): Greek yogurt (plain, 2%, 5 to 6 oz) with a small handful of berries. Or a protein shake (20 to 25 g protein, low fat, blended with ice). The goal is to get protein in early before nausea peaks.

• Meal 2 (3 to 4 hours later): Cold protein source. Deli turkey or chicken (2 to 3 oz) with cucumber slices and a small amount of hummus. Or cottage cheese (1/2 cup) with pineapple. Avoid hot, greasy, or heavily seasoned foods.

• Meal 3 (3 to 4 hours later): Scrambled eggs (2 eggs) with spinach, cooked with minimal oil. Or a small portion of grilled chicken (3 to 4 oz) with steamed broccoli. Room temperature or slightly warm is better tolerated than hot.

• Meal 4 (optional, if tolerated): Protein-based snack. Hard-boiled egg, string cheese, or a small protein bar (10 to 15 g protein, under 200 calories).

Total intake for the 48-hour period: aim for 60 to 80 g of protein and 1,000 to 1,200 calories. If nausea prevents that, 50 g of protein and 800 calories is acceptable. The priority is avoiding vomiting, which can lead to dehydration and electrolyte imbalance.

What to avoid in the first 48 hours: fried foods, red meat, full-fat dairy, raw vegetables (they are harder to digest), carbonated beverages, and alcohol. All of these increase nausea risk or delay gastric emptying.

Protein targets by dose: a practical table

Dose	Phase	Protein target (g/lb goal weight)	Daily protein for 150 lb goal weight	Daily protein for 180 lb goal weight	Daily protein for 200 lb goal weight	Meal frequency	Notes
2.5 mg	Titration	0.6 - 0.7	90 - 105 g	108 - 126 g	120 - 140 g	4-6 small meals	Nausea common, prioritize tolerance
5 mg	Titration	0.6 - 0.7	90 - 105 g	108 - 126 g	120 - 140 g	4-6 small meals	Appetite suppression stabilizing
7.5 mg	Maintenance	0.8 - 1.0	120 - 150 g	144 - 180 g	160 - 200 g	3 structured meals	Nausea less frequent
10 mg	Maintenance	0.8 - 1.0	120 - 150 g	144 - 180 g	160 - 200 g	3 structured meals	Appetite predictable
12.5 mg	Maximum suppression	1.0 - 1.2	150 - 180 g	180 - 216 g	200 - 240 g	3 meals + 1-2 snacks	Muscle preservation priority
15 mg	Maximum suppression	1.0 - 1.2	150 - 180 g	180 - 216 g	200 - 240 g	3 meals + 1-2 snacks	Schedule eating, do not wait for hunger

These targets assume you are in a caloric deficit for weight loss. If you are in maintenance (goal weight reached), protein targets stay the same but total caloric intake increases by adding carbohydrates and fats around the protein base.

When a meal plan PDF actually helps (and when it sabotages progress)

A downloadable meal plan PDF has exactly two legitimate uses on Zepbound:

Use 1: Shopping list generation. A well-designed PDF that lists 20 to 30 tirzepatide-friendly staple foods (lean proteins, low-fat dairy, non-starchy vegetables, moderate-glycemic carbs, healthy fats in small portions) helps you stock your kitchen. The list prevents decision fatigue at the grocery store and reduces the chance you will buy foods that trigger nausea or defeat your deficit.

Use 2: Meal-prep accountability. A PDF with blank meal-logging boxes (Meal 1: protein source, vegetable, carb; Meal 2: protein source, vegetable, carb) provides structure without dictating portions. You fill in what you actually ate and check off whether you hit your protein minimum. This is useful for people who need external accountability.

A meal plan PDF sabotages progress when it does any of the following:

1. Prescribes exact portions. "6 oz chicken breast" is meaningless when you feel full after 3 oz. Forcing the remaining 3 oz trains you to override satiety, which is the opposite of what tirzepatide is designed to teach.

1. Ignores nausea variability. A plan that includes salmon, avocado, and roasted Brussels sprouts on day 4 post-injection (peak nausea window) is setting you up to vomit or skip the meal entirely.

1. Locks you into meal timing. "Breakfast at 7 AM, lunch at 12 PM, dinner at 6 PM" does not account for the fact that your first meal might sit in your stomach until 2 PM, making a noon lunch impossible.

1. Treats all doses the same. A PDF that does not differentiate between 2.5 mg and 15 mg eating strategies is clinically useless.

The pattern we see across patients who successfully use meal plan PDFs: they treat the PDF as a reference menu, not a prescription. They pick meals from the list based on current tolerance, adjust portions to satiety, and skip meals that do not sound appealing. The PDF is a tool, not a rule book.

The strongest case against flexible eating on Zepbound

The best argument for a structured meal plan, even a rigid one, is that some people lose weight more successfully with external rules than with internal cues. This is not a fringe position. It is supported by decades of behavioral weight-loss research showing that self-monitoring, pre-planning, and reduced decision-making all correlate with better adherence (Burke et al., Journal of Medical Internet Research 2011; Painter et al., American Journal of Preventive Medicine 2017).

The concern with flexible, intuitive eating on tirzepatide is that appetite suppression can mask inadequate nutrition. If you are "listening to your body" and your body is telling you to eat 900 calories per day with 40 g of protein, you are on a path to muscle loss, hair thinning, fatigue, and metabolic slowdown. A structured plan with minimum targets prevents that.

The second concern is that flexible eating requires a level of nutritional literacy most people do not have. Knowing that 4 oz of chicken has approximately 35 g of protein, that Greek yogurt has 15 to 20 g per cup, and that you need to hit 120 g per day requires either prior knowledge or constant calculation. A PDF that says "Meal 1: 2 eggs, 1 cup Greek yogurt, 1/2 cup berries" does the math for you.

The third concern is psychological. Some people experience the lack of structure as anxiety-inducing. "What should I eat?" becomes a daily stressor. A plan, even an imperfect one, removes that decision burden.

When a structured plan is the better choice:

• You have a history of disordered eating (binge eating disorder, restrictive eating) and need external guardrails to prevent relapse.
• You are consistently under-eating protein (below 0.6 g per pound of goal weight) because you "do not feel like eating."
• You have lost more than 2 pounds per week for three consecutive weeks, which suggests excessive caloric restriction.
• You are experiencing fatigue, dizziness, hair loss, or other signs of malnutrition.

In these cases, a structured meal plan with minimum calorie and protein targets is a medical intervention, not a preference. The plan should come from a registered dietitian or your prescribing provider, not a generic PDF.

A weekly decision tree for adjusting your approach

Start of each week (or after a dose increase):

Question 1: Did I hit my protein minimum on at least 5 of the last 7 days?

• Yes → Continue current approach.
• No → Switch to structured meal plan with pre-portioned protein sources for the next 7 days. Re-evaluate next week.

Question 2: Did I experience nausea on more than 3 of the last 7 days?

• Yes → Shift to cold, bland, small-frequent-meal protocol. Reduce fat intake. Consider anti-nausea strategies (see our guide on managing Zepbound nausea).
• No → Nausea is controlled. You can eat a wider variety of foods.

Question 3: Did I feel uncomfortably full or experience reflux after meals?

• Yes → Reduce portion sizes by 25%. Eat more slowly (20+ minutes per meal). Avoid lying down within 2 hours of eating.
• No → Current portions are appropriate.

Question 4: Did I lose more than 2 pounds this week?

• Yes, and I am in weeks 1-12 → This is expected. Monitor for fatigue or dizziness.
• Yes, and I am in weeks 13+ → Increase caloric intake by 100-200 calories per day (add a snack or increase carb portions). Recheck next week.
• No, and I am in weeks 1-12 → This is normal. Weight loss is not linear.
• No, and I am in weeks 13+, and I have not lost weight in 3+ weeks → Evaluate total caloric intake. You may have adapted. Consider increasing activity or reducing caloric intake by 100-150 calories per day.

Question 5: Am I experiencing new or worsening fatigue, hair thinning, or cold intolerance?

• Yes → Contact your provider. These are signs of possible malnutrition or thyroid changes. Do not adjust your plan without clinical input.
• No → Current nutrition is adequate.

This decision tree replaces "follow the plan no matter what" with "adjust based on data." It treats your eating pattern as a feedback loop, not a fixed protocol.

Better resources than a generic PDF

If you are looking for structured guidance, these resources are more useful than a downloadable meal plan PDF:

1. A registered dietitian consult (covered by many insurance plans). A single 60-minute session with an RD who specializes in GLP-1 medications will produce a personalized plan that accounts for your dose, food preferences, nausea patterns, and weight-loss goals. This is not a generic PDF. It is a clinical assessment.

2. The USDA MyPlate builder tool (free, online). You input your age, sex, weight, activity level, and goal, and it generates daily targets for protein, vegetables, fruits, grains, and dairy. It does not prescribe specific meals, but it gives you the macro framework to build your own.

3. A meal-tracking app with a protein-minimum alert. Apps like Cronometer or MyFitnessPal allow you to set a daily protein minimum and will flag days when you fall short. This provides accountability without rigidity.

4. FormBlends's GLP-1 nutrition guide (available in your patient portal). This is a 12-page evidence-based guide that covers protein targets by dose, nausea-adaptive meal ideas, and a sample 7-day flexible meal framework. It is designed specifically for compounded semaglutide and tirzepatide patients, not the general public.

5. A simple protein-first plate template. No PDF needed. Every meal: half the plate is non-starchy vegetables, one-quarter is lean protein (palm-sized portion), one-quarter is a carbohydrate (fist-sized portion). Adjust portions to satiety. This is the framework used in the Diabetes Prevention Program and adapted for GLP-1 use (Knowler et al., NEJM 2002).

None of these require you to eat exactly 4 oz of chicken at exactly 6 PM. All of them provide structure without overriding the medication's appetite-regulating effects.

FAQ

Do I need a special diet plan for Zepbound? No. Tirzepatide works by suppressing appetite and slowing gastric emptying, which naturally reduces caloric intake. The most effective approach is protein-first eating (0.8 to 1.0 g per pound of goal weight), a moderate caloric deficit (500 calories below maintenance), and listening to satiety cues. Structured meal plans help some people with accountability but are not required for success.

Can I eat carbs on Zepbound? Yes. Tirzepatide improves insulin sensitivity and glycemic control, so moderate carbohydrate intake (40 to 45% of total calories) is well-tolerated. Prioritize complex carbs (whole grains, legumes, starchy vegetables) over refined carbs. Eating protein before carbs at each meal further blunts glucose spikes.

How much protein should I eat on Zepbound? Target 0.8 to 1.0 g of protein per pound of goal body weight during maintenance doses (7.5 mg to 10 mg), and 1.0 to 1.2 g per pound at maximum suppression doses (12.5 mg to 15 mg). During titration (2.5 mg to 5 mg), 0.6 to 0.7 g per pound is acceptable if nausea limits intake. Spread protein across 3 to 4 meals for better absorption.

What should I eat if I feel nauseous on Zepbound? Cold, bland, protein-rich foods are best tolerated during nausea. Examples: Greek yogurt, cottage cheese, deli turkey, hard-boiled eggs, protein shakes blended with ice, and applesauce. Avoid high-fat, fried, spicy, or heavily seasoned foods. Small, frequent meals (every 3 to 4 hours) work better than three large meals.

Can I follow a keto or low-carb diet on Zepbound? You can, but it is not necessary. Tirzepatide already improves insulin sensitivity and reduces glucose spikes, so the metabolic benefits of keto are partially redundant. Some patients find that very low-carb diets (under 50 g per day) worsen nausea or fatigue on tirzepatide. If you prefer keto, monitor for these side effects and adjust as needed.

Should I eat breakfast on Zepbound even if I am not hungry? Yes, especially at higher doses (10 mg and above). Appetite suppression can be so strong that you forget to eat, leading to inadequate protein and calorie intake. Eating a small, protein-rich breakfast (even if it is just a protein shake or Greek yogurt) prevents under-eating later in the day and supports muscle preservation.

How many calories should I eat on Zepbound? Most patients naturally reduce intake to 1,200 to 1,500 calories per day on therapeutic doses (7.5 mg and above). The minimum safe intake for most adults is 1,200 calories per day for women and 1,500 for men, though individual needs vary. If you are consistently below these thresholds, you risk malnutrition. Work with your provider to adjust your approach.

Can I drink alcohol on Zepbound? Alcohol is not contraindicated, but it is poorly tolerated by many patients on tirzepatide. Alcohol delays gastric emptying (compounding the medication's effect), increases nausea risk, and adds empty calories that can stall weight loss. If you drink, limit intake to 1 to 2 drinks per week and avoid drinking on an empty stomach.

What foods should I avoid on Zepbound? Avoid high-fat foods (fried foods, fatty cuts of meat, full-fat dairy, heavy sauces), which worsen nausea and reflux. Avoid carbonated beverages, which increase bloating. Avoid very large portions, which trigger early satiety and discomfort. There are no absolute food restrictions, but these categories are poorly tolerated by most patients.

Do I need to take vitamins on Zepbound? If you are eating a varied diet with adequate protein and vegetables, additional supplementation is usually not necessary. However, if your caloric intake is consistently below 1,200 calories per day, consider a daily multivitamin to cover micronutrient gaps. Vitamin D and B12 are the most common deficiencies in patients on long-term GLP-1 therapy.

Can I eat out at restaurants on Zepbound? Yes. Order protein-forward dishes (grilled chicken, fish, steak) and ask for vegetables instead of fries or rice. Request sauces and dressings on the side. Eat slowly and stop when you feel full, even if food remains on the plate. Leftovers are expected on tirzepatide. Avoid buffets and all-you-can-eat settings, which encourage overeating.

How do I prevent muscle loss on Zepbound? Prioritize protein intake (1.0 to 1.2 g per pound of goal weight at higher doses), engage in resistance training at least twice per week, and avoid excessive caloric deficits (stay above 1,200 to 1,500 calories per day). Rapid weight loss (more than 2 pounds per week after the first month) increases muscle loss risk. Slow, steady loss preserves lean mass better.

Sources

1. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
2. Garvey WT et al. Tirzepatide Once Weekly for the Treatment of Obesity in People with Type 2 Diabetes (SURMOUNT-2): A Double-Blind, Randomised, Multicentre, Placebo-Controlled, Phase 3 Trial. Lancet. 2023.
3. Wilding JPH et al. Weight Regain and Cardiometabolic Effects After Withdrawal of Semaglutide: The STEP 1 Trial Extension. Diabetes, Obesity and Metabolism. 2022.
4. Knowler WC et al. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. New England Journal of Medicine. 2002.
5. Burke LE et al. Self-Monitoring in Weight Loss: A Systematic Review of the Literature. Journal of Medical Internet Research. 2011.
6. Painter SL et al. What Matters in Weight Loss? An In-Depth Analysis of Self-Monitoring. American Journal of Preventive Medicine. 2017.
7. Holt SHA et al. A Satiety Index of Common Foods. European Journal of Clinical Nutrition. 1995.
8. Drewnowski A. Energy Density, Portion Size, and Eating Occasions: Contributions to Increased Energy Intake in the United States, 1977-2006. Annual Review of Nutrition. 2018.
9. Blundell J et al. Effects of Once-Weekly Semaglutide on Appetite, Energy Intake, Control of Eating, Food Preference and Body Weight in Subjects with Obesity. Diabetes, Obesity and Metabolism. 2017.
10. Friedrichsen M et al. The Effect of Semaglutide 2.4 mg Once Weekly on Energy Intake, Appetite, Control of Eating, and Gastric Emptying in Adults with Obesity. Diabetes, Obesity and Metabolism. 2021.
11. Rubino D et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021.
12. Wadden TA et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA. 2021.
13. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
14. U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2020-2025. 9th Edition. December 2020.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Eli Lilly and Company.